- Report
- June 2026
- 200 Pages
Global
From €2694EUR$2,990USD£2,311GBP
- Report
- November 2025
- 150 Pages
Global
From €5361EUR$5,950USD£4,600GBP
- Report
- December 2025
- 120 Pages
Global
From €5361EUR$5,950USD£4,600GBP
- Report
- April 2026
- 135 Pages
Global
From €2702EUR$2,999USD£2,318GBP
€3603EUR$3,999USD£3,091GBP
- Report
- December 2025
- 167 Pages
Global
From €4415EUR$4,900USD£3,788GBP
- Report
- October 2025
- 100 Pages
Global
From €4415EUR$4,900USD£3,788GBP
- Report
- October 2025
- 146 Pages
Global
From €4415EUR$4,900USD£3,788GBP
- Report
- January 2026
- 188 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- January 2026
- 193 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- May 2026
- 185 Pages
Global
From €4055EUR$4,500USD£3,479GBP
- Report
- May 2026
- 180 Pages
Global
From €4055EUR$4,500USD£3,479GBP
- Report
- September 2026
- 191 Pages
Global
From €3194EUR$3,545USD£2,740GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 198 Pages
Global
From €3194EUR$3,545USD£2,740GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 199 Pages
Global
From €3194EUR$3,545USD£2,740GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 188 Pages
Global
From €3194EUR$3,545USD£2,740GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 191 Pages
Global
From €3194EUR$3,545USD£2,740GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 182 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 183 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- November 2025
- 188 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,471GBP

The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more